Targeted AML therapy: New biologic paradigms and therapeutic opportunities

Research output: Contribution to journal › Review article › peer-review

ASJC Scopus subject areas

@article{ca8941e6cd7545c2a2702d283023562f,

title = "Targeted AML therapy: New biologic paradigms and therapeutic opportunities",

author = "Willman, {C. L.}",

year = "2001",

doi = "10.1038/sj.leu.2402087",

language = "English (US)",

volume = "15",

pages = "690--694",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - Targeted AML therapy

T2 - New biologic paradigms and therapeutic opportunities

AU - Willman, C. L.

PY - 2001

Y1 - 2001

UR - http://www.scopus.com/inward/record.url?scp=0035065917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035065917&partnerID=8YFLogxK

U2 - 10.1038/sj.leu.2402087

DO - 10.1038/sj.leu.2402087

M3 - Review article

C2 - 11368384

AN - SCOPUS:0035065917

SN - 0887-6924

VL - 15

SP - 690

EP - 694

JO - Leukemia

JF - Leukemia

IS - 4

ER -